Lin MH, et al. Real-world brigatinib use in non-small cell lung cancer patients with prior use of crizotinib/other ALK therapies in the US. Abstract P2.16-09. WCLC 2019, 7-10 sept. Barcelona, Spanje.
Máxima-topman Eggermont: ‘We beseffen niet hoe ver we vóórlopen’
jul 2020